We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Neurons Grown from Skin Cells May Hold Clues to Autism

By LabMedica International staff writers
Posted on 28 Dec 2011
Potential insights into how autism disrupts the brain are emerging from research into a rare genetic form of the disorders that affects fewer than 20 individuals worldwide. More...
Using a groundbreaking “disease-in a-dish” technique, researchers have grown patients’ skin cells into neurons to discover what goes wrong in the brain in Timothy syndrome.

Affected children with this disorder frequently show symptoms of autism spectrum disorders combined with a constellation of physical problems. Abnormalities included changes in the composition of cells in the cortex, the largest brain structure in humans, and of neurons that secrete two key chemical messengers. Neurons that make long-distance connections between the brain’s hemispheres tended to be in short supply.

Most patients with Timothy syndrome meet diagnostic criteria for an autism spectrum disorder. However, unlike most cases of autism, Timothy syndrome is known to be caused by a single genetic mutation. “Studying the consequences of a single mutation, compared to multiple genes with small effects, vastly simplifies the task of pinpointing causal mechanisms,” explained Ricardo Dolmetsch, PhD, from Stanford University (Stanford, CA, USA), a US National Institute of Mental Health (NIMH; Bethesda, MD, USA) grantee who led the study.

Dr. Dolmetsch, and colleagues, reported on their findings November 27, 2011, in the journal Nature Medicine. “Unlike animal research, the cutting-edge technology employed in this study makes it possible to pinpoint molecular defects in a patient’s own brain cells,” said NIMH director Thomas R. Insel, MD. “It also offers a way to screen more rapidly for medications that act on the disordered process.”

Before this research, researchers knew that Timothy syndrome is caused by a tiny malfunction in the gene which codes for a calcium channel protein in cell membranes. The mutation results in too much calcium entering cells, causing a characteristic set of abnormalities throughout the body. Accurate functioning of the calcium channel is known to be particularly critical for proper heart rhythm--many patients die in childhood of arrhythmias--but its role in brain cells was less well understood.

To understand more, Dr. Dolmetsch and colleagues used a new technology called induced pluripotent stem cells (iPSCs). They first transformed skin cells from Timothy syndrome patients into stem cells and then coaxed these to differentiate into neurons.

“Remarkable reproducibility” observed across multiple iPSC lines and individuals validated that the technique can reveal defects in neuronal differentiation--such as whether cells assume the correct identity as the brain gets wired-up in early development, said the researchers. Compared to those from controls, fewer neurons from Timothy syndrome patients became neurons of the lower layers of the cortex and more became upper layer neurons. The lower layer cells that remained were more likely to be the sort that project to areas below the cortex. In comparison, there were fewer-than-normal neurons equipped to form a structure, called the corpus callosum, which makes possible communications between the left and right hemispheres.

Many of these defects were also seen in equivalent studies of mice with the same genetic mutation found in Timothy syndrome patients. This supports the link between the mutation and the developmental abnormalities.

Several genes earlier implicated in autism were among hundreds found to be expressed abnormally in Timothy syndrome neurons. Excess cellular calcium levels also caused an overproduction of neurons that make key chemical messengers. Timothy syndrome neurons secreted 3.5 times more norepinephrine and 2.3 times more dopamine than control neurons. Addition of a drug that blocks the calcium channel reversed the abnormalities in cultured neurons, reducing the proportion of catecholamine-secreting cells by 68%.

The findings in Timothy syndrome patient iPSCs follow those in Rett syndrome, another single gene disorder that frequently includes autism-like symptoms. About one year ago, Alysson Muotri, PhD, and colleagues at University of California, San Diego (USA), reported deficits in the protrusions of neurons, called spines, which help form connections, or synapses. The scientists’ discovery of earlier (neuronal fate) and later (altered connectivity) defects suggest that disorders on the autism spectrum affect multiple stages in early brain development.

“Most of these abnormalities are consistent with other emerging evidence that ASDs arise from defects in connectivity between cortex areas and show decreased size of the corpus callosum,” concluded Dr. Dolmetsch. “Our study reveals how these might be traceable to specific mechanisms set in motion by poor regulation of cellular calcium. It also demonstrates that neurons derived from iPSCs can be used to identify the cellular basis of a neurodevelopmental disorder.”

The processes identified in this study may become potential targets for developing new therapies for Timothy Syndrome and may also provide insights into the neural basis of deficits in other forms of autism, according to Dr. Dolmetsch.

Related Links:
Stanford University
National Institute of Mental Health


New
Gold Member
Cardiovascular Risk Test
Metabolic Syndrome Array I & II
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Anterior Nasal Specimen Collection Swabs
53-1195-TFS, 53-0100-TFS, 53-0101-TFS, 53-4582-TFS
New
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: A simple blood sample that allows DNA methylation could identify epigenetic biomarkers (Photo courtesy of 123RF)

Simple Blood Sample Could Identify Epigenetic Biomarkers to Predict CVD Risk in Type 2 Diabetes

People with type 2 diabetes face up to four times higher risk of cardiovascular events such as heart attacks, strokes, and angina compared to individuals without the condition. Yet, current tools used... Read more

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: The new technology could predict who will benefit from immunotherapy (Photo courtesy of Max Delbrück Center)

New Technology Deciphers Immune Cell Communication to Predict Immunotherapy Response

A healthy immune system depends on complex communication between specialized cell types that detect, alert, and eliminate harmful threats. When these immune signaling pathways break down, the result can... Read more

Microbiology

view channel
Image: MycoMEIA Aspergillus Assay is the first FDA-cleared urine-based test for invasive aspergillosis (Photo courtesy of Pearl Diagnostics)

Urine-Based Assay Diagnoses Common Lung Infection in Immunocompromised People

Invasive Aspergillosis (IA), a life-threatening fungal infection, poses a serious threat to immunocompromised individuals, especially those with hematologic malignancies, transplants, or severe lung diseases.... Read more

Industry

view channel
Image: The acquisition of Exosome Diagnostics adds the ExoDx Prostate test to Mdxhealth’s portfolio (Photo courtesy of Bio-Techne)

Bio-Techne Divests Exosome Diagnostics to Reposition Product Portfolio

Bio-Techne Corporation (Minneapolis, MN, USA) has entered into an agreement with Mdxhealth SA (Irvine, CA, USA), which will acquire its Exosome Diagnostics Inc. (Waltham, MA, US) business, including the... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.